Who
Catherine Moukheibir
Director
Company insider
Files Form 4 as: Director, MoonLake Immunotherapeutics; Director, Ironwood Pharmaceuticals.
In numbers
- Trades disclosed
- 30
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $1.7M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 1 Apr 2019
- Last trade
- 17 Jun 2026
- Last filed
- 18 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 18 Jun 2026 | MLTX MoonLake Immunotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,195 at $0.00 | filing |
| 17 Jun 2026filed 18 Jun 2026 | MLTX MoonLake Immunotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,195 at $0.00 | filing |
| 16 Jun 2026filed 17 Jun 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —63,481 at $0.00 | filing |
| 16 Jun 2026filed 17 Jun 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —63,481 at $0.00 | filing |
| 3 Jul 2025filed 7 Jul 2025 | MLTX MoonLake Immunotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —23,500 at $0.00 | filing |
| 3 Jul 2025filed 7 Jul 2025 | MLTX MoonLake ImmunotherapeuticsBiotechnology | SEC FORM 4 Code M | —23,500 at $0.00 | filing |
| 3 Jul 2025filed 7 Jul 2025 | MLTX MoonLake ImmunotherapeuticsBiotechnology | SEC FORM 4 Sold | $1.1M23,500 at $48.79 | filing |
| 10 Jun 2025filed 12 Jun 2025 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | MLTX MoonLake Immunotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,682 at $0.00 | filing |
| 18 Jun 2024filed 21 Jun 2024 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —24,311 at $0.00 | filing |
| 7 Jun 2024filed 10 Jun 2024 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $235K35,574 at $6.61 | filing |
| 6 Jun 2024filed 10 Jun 2024 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $283K44,426 at $6.36 | filing |
| 6 Jun 2024filed 7 Jun 2024 | MLTX MoonLake Immunotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,688 at $0.00 | filing |
| 15 Dec 2023filed 19 Dec 2023 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,572 at $0.00 | filing |
| 15 Sep 2023filed 19 Sep 2023 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —2,098 at $0.00 | filing |
| 20 Jun 2023filed 22 Jun 2023 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —22,350 at $0.00 | filing |
| 15 Jun 2023filed 20 Jun 2023 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,586 at $0.00 | filing |
| 8 Jun 2023filed 12 Jun 2023 | MLTX MoonLake Immunotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,297 at $0.00 | filing |
| 15 Mar 2023filed 17 Mar 2023 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —1,677 at $0.00 | filing |
| 1 Jun 2022filed 3 Jun 2022 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —21,571 at $0.00 | filing |
News
Ironwood Pharmaceuticals (NASDAQ:IRWD) and Exicure (NASDAQ:XCUR) Financial ComparisonIRWD · tickerreport.com · 15 Oct 2026
0 headlines in the last 90 days name Catherine Moukheibir; 1 article from the last 14 days about the 2 companies they traded most, at most three about any one of them.